The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets, and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.
2020
881
LTM Revenue $329M
LTM EBITDA $3.4M
$409M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Beauty Health has a last 12-month revenue of $329M and a last 12-month EBITDA of $3.4M.
In the most recent fiscal year, Beauty Health achieved revenue of $398M and an EBITDA of -$53.6M.
Beauty Health expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Beauty Health valuation multiples based on analyst estimatesFY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $366M | $398M | $328M | $329M | XXX |
Gross Profit | $182M | $250M | $155M | XXX | XXX |
Gross Margin | 50% | 63% | 47% | XXX | XXX |
EBITDA | $81.3M | -$53.6M | $1.5M | $3.4M | XXX |
EBITDA Margin | 22% | -13% | 0% | 1% | XXX |
Net Profit | -$375M | $44.4M | -$100M | XXX | XXX |
Net Margin | -103% | 11% | -30% | XXX | XXX |
Net Debt | n/a | $166M | $215M | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 21, 2025, Beauty Health's stock price is $2.
Beauty Health has current market cap of $200M, and EV of $409M.
See Beauty Health trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$409M | $200M | XXX | XXX | XXX | XXX | $-0.28 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 21, 2025, Beauty Health has market cap of $200M and EV of $409M.
Beauty Health's trades at 1.2x LTM EV/Revenue multiple, and 120.6x LTM EBITDA.
Analysts estimate Beauty Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Beauty Health and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $409M | XXX | XXX | XXX |
EV/Revenue | 1.2x | XXX | XXX | XXX |
EV/EBITDA | 264.2x | XXX | XXX | XXX |
P/E | -6.1x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -68.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpBeauty Health's NTM/LTM revenue growth is 3%
Beauty Health's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, Beauty Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Beauty Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Beauty Health and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -17% | XXX | XXX | XXX | XXX |
EBITDA Margin | 0% | XXX | XXX | XXX | XXX |
EBITDA Growth | -103% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 3% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.5M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 36% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 33% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
Opex to Revenue | 72% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Beauty Health acquired XXX companies to date.
Last acquisition by Beauty Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Beauty Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Beauty Health founded? | Beauty Health was founded in 2020. |
Where is Beauty Health headquartered? | Beauty Health is headquartered in United States of America. |
How many employees does Beauty Health have? | As of today, Beauty Health has 881 employees. |
Who is the CEO of Beauty Health? | Beauty Health's CEO is Ms. Marla Malcolm Beck. |
Is Beauty Health publicy listed? | Yes, Beauty Health is a public company listed on NAS. |
What is the stock symbol of Beauty Health? | Beauty Health trades under SKIN ticker. |
When did Beauty Health go public? | Beauty Health went public in 2021. |
Who are competitors of Beauty Health? | Similar companies to Beauty Health include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
What is the current market cap of Beauty Health? | Beauty Health's current market cap is $200M |
What is the current revenue of Beauty Health? | Beauty Health's last 12-month revenue is $329M. |
What is the current EBITDA of Beauty Health? | Beauty Health's last 12-month EBITDA is $3.4M. |
What is the current EV/Revenue multiple of Beauty Health? | Current revenue multiple of Beauty Health is 1.2x. |
What is the current EV/EBITDA multiple of Beauty Health? | Current EBITDA multiple of Beauty Health is 120.6x. |
What is the current revenue growth of Beauty Health? | Beauty Health revenue growth between 2023 and 2024 was -17%. |
Is Beauty Health profitable? | Yes, Beauty Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.